Journal of Cancer Therapy
Vol.4 No.7(2013), Paper ID 35986, 5
pages
DOI:10.4236/jct.2013.47135
Circulating Tumor Cell Cultures as a Predictive Marker during Salvage Therapy of Refractory Merkel Cell Carcinoma with Chemotherapy and Electron Beam Radiation
Sreekanth Donepudi, Susan A. Reisinger, John R. McGregor, Shweta Tharkar, Suzanne Samlowski, Daniel Ostler, Shirley Shen, Wolfram E. Samlowski
Comprehensive Cancer Centers of Nevada, Las Vegas, USA
21st Century Radiation Oncology, Las Vegas, USA
TrueCells, LLC, Las Vegas, USA
TrueCells, LLC, Las Vegas, USA
TrueCells, LLC, Las Vegas, USA
LMC Pathology, Las Vegas, USA
Genomics Core Facility of UNLV, Las Vegas, USA
Comprehensive Cancer Centers of Nevada, Las Vegas, USA
Copyright © 2013 Sreekanth Donepudi, Susan A. Reisinger, John R. McGregor, Shweta Tharkar, Suzanne Samlowski, Daniel Ostler, Shirley Shen, Wolfram E. Samlowski et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
S. Donepudi, S. Reisinger, J. McGregor, S. Tharkar, S. Samlowski, D. Ostler, S. Shen and W. Samlowski, "Circulating Tumor Cell Cultures as a Predictive Marker during Salvage Therapy of Refractory Merkel Cell Carcinoma with Chemotherapy and Electron Beam Radiation,"
Journal of Cancer Therapy, Vol. 4 No. 7, 2013, pp. 1162-1166. doi:
10.4236/jct.2013.47135.